Aug 12, 2009 | Laboratory News, Laboratory Pathology
Effort will identify which clinical procedures actually benefit patients—and are cost-effective “Comparative effectiveness research (CER)” is likely to be one method that healthcare reformers use to establish reimbursement for different medical technologies and treatments. This will apply equally to clinical laboratory testing and pathology professional services as well as other medical procedures. There is a compelling reason why comparative effectiveness is likely to happen on this turn of...
